G01N 2800/04
Endocrine or metabolic disorders
G01N2800/04 (Endocrine or metabolic disorders) appears on 1,592 US grants and 2,924 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,592
- Published applications
- 2,924
- Assignees
- 1,176
- Inventors
- 4,557
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 7 | 0 |
| 1981 | 4 | 0 |
| 1982 | 4 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 6 | 0 |
| 1989 | 6 | 0 |
| 1990 | 5 | 0 |
| 1991 | 2 | 0 |
| 1992 | 8 | 0 |
| 1993 | 16 | 0 |
| 1994 | 10 | 0 |
| 1995 | 18 | 0 |
| 1996 | 10 | 0 |
| 1997 | 23 | 0 |
| 1998 | 39 | 0 |
| 1999 | 19 | 0 |
| 2000 | 18 | 0 |
| 2001 | 22 | 6 |
| 2002 | 18 | 58 |
| 2003 | 20 | 504 |
| 2004 | 32 | 81 |
| 2005 | 27 | 109 |
| 2006 | 34 | 103 |
| 2007 | 98 | 102 |
| 2008 | 90 | 80 |
| 2009 | 47 | 109 |
| 2010 | 49 | 144 |
| 2011 | 55 | 136 |
| 2012 | 66 | 127 |
| 2013 | 74 | 109 |
| 2014 | 57 | 106 |
| 2015 | 76 | 120 |
| 2016 | 64 | 126 |
| 2017 | 57 | 106 |
| 2018 | 80 | 165 |
| 2019 | 93 | 121 |
| 2020 | 75 | 107 |
| 2021 | 60 | 94 |
| 2022 | 52 | 68 |
| 2023 | 35 | 66 |
| 2024 | 41 | 76 |
| 2025 | 30 | 55 |
| 2026 | 24 | 46 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Continuous glucose monitoring trend-enabled dose calculator25 Aug 2026US 12,714,786 B2Companion Medical, Inc.
- Pharmaceutical composition for lowering blood cholesterol, preventing or treating cardiovascular diseases and reducing inflammation25 Aug 2026US 12,715,899 B2Seoul National University Hospital
- LAMA2, PLXDC2 and MLL4 as novel biomarkers for prediabetes and diabetes18 Aug 2026US 12,710,430 B2Academia Sinica
- Anti-IDE antibodies and uses of same4 Aug 2026US 12,698,344 B2Ramot at Tel-Aviv University Ltd.
- Compositions and methods for detecting autoantibodies14 Jul 2026US 12,681,016 B2Ortho-Clinical Diagnostics, Inc.
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Electrochemical aptamer biosensor for detecting phenylalanine and/or tyrosine24 Sep 2026US 2026/0287542 A1Seoul Women's University Industry-University Cooperation Foundation
- Diagnosis, monitoring or prognosis of type 2 diabetes, impaired glucose tolerance or prediabetes17 Sep 2026US 2026/0276653 A1FundacióN PúBlica Galega Instituto De InvestigacióN Sanitaria De Santiago De Compostela
- Methods of estimating blood glucose and related systems17 Sep 2026US 2026/0276659 A1The General Hospital Corporation
Most cited
By later US patents
- Polarographic analysis of cholesterol and other macromolecular substances381US 4,040,908 AChildren's Hospital Medical Center · 1977
- Methods of activating a melanocortin-4 receptor pathway in obese subjects277US 8,476,227 B2Ethicon Endo-Surgery, Inc. · 2013
- Method and apparatus for measuring classes and subclasses of lipoproteins153US 5,343,389 ANorth Carolina State University · 1994
- Inhibitors of microsomal triglyceride transfer protein and method137US 5,712,279 ABristol-Myers Squibb Company · 1998
- Inhibitors of microsomal triglyceride transfer protein and method129US 5,739,135 ABristol-Myers Squibb Company · 1998